Turn Therapeutics Inc.
TTRX
$3.98
$0.102.58%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 496.90K | -- | -- | -- | -- |
| Gross Profit | -496.90K | -- | -- | -- | -- |
| SG&A Expenses | 2.16M | 1.75M | 1.30M | 839.80K | 319.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.69M | 1.91M | 1.37M | 875.80K | 329.00K |
| Operating Income | -2.69M | -1.91M | -1.37M | -875.80K | -329.00K |
| Income Before Tax | 279.10K | -1.90M | -1.24M | -784.50K | -323.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 279.10K | -1.90M | -1.24M | -784.50K | -323.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 279.10K | -1.90M | -1.24M | -784.50K | -323.10K |
| EBIT | -2.69M | -1.91M | -1.37M | -875.80K | -329.00K |
| EBITDA | -2.68M | -1.90M | -1.35M | -863.30K | -316.60K |
| EPS Basic | 0.01 | -0.07 | -0.05 | -0.03 | -0.01 |
| Normalized Basic EPS | 0.01 | -0.04 | -0.03 | -0.02 | -0.01 |
| EPS Diluted | 0.01 | -0.07 | -0.05 | -0.03 | -0.01 |
| Normalized Diluted EPS | 0.01 | -0.04 | -0.03 | -0.02 | -0.01 |
| Average Basic Shares Outstanding | 28.43M | 27.98M | 27.49M | 27.20M | 26.93M |
| Average Diluted Shares Outstanding | 28.43M | 27.98M | 27.49M | 27.20M | 26.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |